Johnson & Johnson Press Releases

JNJ 
$98.96
*  
0.21
 negative 
0.21%
Get JNJ Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

New Recycling Study Shows Lack Of Bins Is No. 1 Barrier To Recycling In The Home
4/17/2014 10:14:00 AM - PR Newswire

VisionCare Appoints Industry Veterans, Mark Forchette, and John Ryan of ONSET Ventures to its Board of Directors
4/15/2014 2:45:00 PM - PR Newswire

Johnson & Johnson Reports 2014 First-Quarter Results:
4/15/2014 7:45:00 AM - PR Newswire

Technical Pointers on Pharmaceuticals Equities -- Research on Merck, Bristol-Myers Squibb, Johnson & Johnson, and Eli Lilly
4/7/2014 12:34:00 PM - PR Newswire

Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals
4/3/2014 8:00:00 AM - PR Newswire

Johnson & Johnson Enters Agreement to be Official Healthcare Partner of the USO
4/1/2014 12:09:00 PM - PR Newswire

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"
3/31/2014 9:15:00 AM - Market Wire

Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
3/31/2014 7:45:00 AM - PR Newswire

VisionCare Announces Management Promotions
3/28/2014 11:00:00 AM - PR Newswire

Positive Opinions, Presentation Schedules of Investigational Data, Clinical Study Results, and Stock Price Movements - Analyst Notes on Johnson & Johnson, Merck, Pfizer, Amgen, and Allergan
3/28/2014 8:00:00 AM - PR Newswire

Johnson & Johnson to Webcast Annual Meeting of Shareholders
3/21/2014 7:45:00 AM - PR Newswire

Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse
3/20/2014 8:00:00 AM - PR Newswire

Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories
3/20/2014 8:00:00 AM - PR Newswire

The LISTERINE® Brand Supports the FDI World Dental Federation In 2014 Global Oral Health Initiative
3/19/2014 12:34:00 PM - PR Newswire

Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly
3/19/2014 8:00:00 AM - PR Newswire

Philadelphia Jury Awards $3 Million in Topamax Birth Defect Trial
3/14/2014 12:44:00 PM - PR Newswire

Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories
3/12/2014 8:00:00 AM - PR Newswire

Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
3/11/2014 4:15:00 PM - PR Newswire

Johnson & Johnson Launches "Champions of Care" Program in the U.S as Part of 2014 FIFA World Cup™ Sponsorship
3/6/2014 1:52:00 PM - PR Newswire

Intact Vascular, Inc. Hires Joseph Griffin as Vice President of Regulatory Affairs and Quality Assurance
2/26/2014 3:38:00 PM - Business Wire

Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation
2/25/2014 9:00:00 AM - Business Wire

Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference
2/25/2014 7:45:00 AM - PR Newswire

Cordis Corporation Receives CE Mark for RENLANE™ Renal Denervation System to Treat Resistant Hypertension
2/21/2014 9:59:00 AM - Business Wire

Cordis Corporation Announces Exclusive Distribution Agreement with TriReme Medical, Inc. for the Chocolate® PTA Balloon Catheter
2/18/2014 1:36:00 PM - Business Wire

Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference
2/14/2014 7:45:00 AM - PR Newswire